PROVIDER PROFILE · NPI 1942314679
Thomas DowlingM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,522
Unique beneficiaries
—
Total services
3,501
Distinct HCPCS
11
Medicare payment
$98K
Peer benchmark
Total Medicare services vs. 141 Otolaryngology providers in AL — top quintile (cohort median 1,570).
PRESCRIBING · PART D · 2024
Total Rx claims
4,349
Beneficiaries
—
Total drug cost
$65K
Distinct drugs
27
Brand share
8.0%
Top prescribed drugs
Levocetirizine Dihydrochloride947 claims
Fluticasone Propionate864 claims
Montelukast Sodium647 claims
Meclizine Hcl311 claims
Triamterene/Hydrochlorothiazid298 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Thomas Dowling's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 23 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 88 | 216 |
| GADSDEN REGIONAL MEDICAL CENTER LLC | 71 | 133 |
| AFFINITY HOSPITAL LLC | 70 | 131 |
| SOLSTAS LAB PARTNERS GROUP LLC | 58 | 145 |
| Jeffrey Martin Dermatology · Fort Myers, FL | 35 | 66 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | 29 | 86 |
| Charles Dabbs Ophthalmology · Gadsden, AL | 22 | 37 |
| JANDER, HARTWIG | 17 | 30 |
| VANORE, JOHN | 16 | 37 |
| Brooke Gorham Podiatry · Gadsden, AL | 16 | 34 |
| Eric Baum Dermatology · Gadsden, AL | 15 | 36 |
| HEAD, GEORGE | 14 | 49 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE